Skip to main content

Michael Naslund, MD, MBA


Authored Items
The Economic Impact of Delaying 5-Alpha Reductase Inhibitor Therapy in Men Receiving Treatment for Symptomatic Benign Prostatic Hyperplasia
Michael Naslund, MD, MBA, Matthew Mitchell, PharmD, MBA, FAMCP, Michael Eaddy, PharmD, PhD, Susan L. Hogue, PharmD, MPH, Eric J. Kruep, PharmD, MS, Manan B. Shah, PharmD, PhD
May/June 2011, Vol 4, No 3 in Original Research, Practice Management
Last modified: June 20, 2011